Alterity Therapeutics ATHE Income Statement (2009-2026)

NASDAQ ATHE
$2.39 -0.04 (-1.65%)
At close: Oct 21, 2026 · 4:00 PM EDT
Reported Financials

Alterity Therapeutics Quarterly Income Statement

Periods 38 quarters
Latest Jun 2026

Alterity Therapeutics income statement data for the quarter ended Jun 2026. This income statement covers 38 quarters of results from Jun 2009 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income StatementIncome Statement Jun2009 Dec2009 Jun2010 Oct2010 Dec2010 Jun2011 Dec2011 Jun2012 Dec2012 Jun2013 Oct2013 Dec2013 Jun2014 Sep2014 Dec2014 Jun2015 Dec2015 Jun2016 Dec2016 Jun2017 Dec2017 Jun2018 Dec2018 Jun2019 Dec2019 Jun2020 Dec2020 Jun2021 Dec2021 Jun2022 Dec2022 Jun2023 Dec2023 Jun2024 Dec2024 Jun2025 Dec2025 Jun2026
Operating items
Depreciation & Amortization - TotalDep. & Amort. (Tot)
Research & DevelopmentR&D
-5.75M-1.76M3.32M-9.25M-8.28M-6.77M-9.47M
Share-based Compensation (IS)Stock Comp.
0.64M0.41M0.20M0.52M1.45M
Selling, General & AdministrativeSG&A
-3.05M-1.52M0.01M-1.88M-2.68M-1.99M-3.40M
Other Operating ExpensesOther Opex
-0.54M-0.09M0.27M0.24M-0.36M-0.30M-0.22M-0.27M
Operating ExpensesOpex
-8.72M-3.21M3.39M0.02M0.02M-11.10M-10.97M-8.75M-12.85M
Operating IncomeOp. Inc
-2.74M-2.78M-3.83M
EBIT
-2.74M-2.78M-3.83M
Non-operating items
Non Operating Interest Expenses
Other Non Operating IncomeOther Non Op Inc.
-0.47M1.78M0.59M0.00M-0.17M-0.02M
Non Operating IncomeNon Op. Inc.
Net income details
EBT
-2.74M-2.78M-3.83M
Profit After TaxPAT
-2.74M-2.78M-3.83M
Income from Continuing OperationsIncome (Continuing)
-2.74M-2.78M-3.83M
Consolidated Net IncomeConsol Net Inc.
-2.74M-2.78M-3.83M
Income towards Parent CompanyParent Net Inc
-2.74M-2.78M-3.83M
Net Income towards Common StockholdersNet Income
-2.74M-2.78M-3.83M
Additional items
EPS (Basic)
-0.06-0.06-0.09
Shares Outstanding
44.49M44.49M44.49M44.49M44.49M51.31M51.31M74.57M74.57M141.41M141.41M200.50M200.50M202.32M202.32M304.07M31.80M533.08M533.08M17.54M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
74.57M74.57M141.41M141.41M200.50M200.50M202.32M202.32M304.07M304.07M533.08M533.08M533.08M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
44.49M44.49M71.74M86.45M173.67M200.57M203.32M437.09M31.80M533.08M18.13M
EBITDA
-2.75M-2.79M-3.84M
Interest ExpensesInt Expense

Alterity Therapeutics Income Statement API

Pull Alterity Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=ATHE&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY